Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Zinc  COVID-19 treatment studies for Zinc  C19 studies: Zinc  Zinc   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Hospitalization 75% Improvement Relative Risk Ekemen Keleş et al. Zinc for COVID-19 Sufficiency Are zinc levels associated with COVID-19 outcomes? Prospective study of 100 patients in Turkey (Aug - Nov 2020) Lower hospitalization with higher zinc levels (p=0.011) Ekemen Keleş et al., European J. Pediatrics, doi:10.1007/s00431-021-04348-w Favors zinc Favors control
Serum zinc levels in pediatric patients with COVID-19
Ekemen Keleş et al., European Journal of Pediatrics, doi:10.1007/s00431-021-04348-w
Ekemen Keleş et al., Serum zinc levels in pediatric patients with COVID-19, European Journal of Pediatrics, doi:10.1007/s00431-021-04348-w
Jan 2022   Source   PDF  
  All Studies   Meta
Prospective study of 100 COVID+ pediatric patients in Turkey, showing significantly increased risk of hospitalization for patients with zinc deficiency.
risk of hospitalization, 75.3% lower, RR 0.25, p = 0.01, high zinc levels (≥70μg/dL) 10 of 89 (11.2%), low zinc levels (<70μg/dL) 5 of 11 (45.5%), NNT 2.9.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ekemen Keleş et al., 22 Jan 2022, prospective, Turkey, peer-reviewed, 7 authors, study period 3 August, 2020 - 15 November, 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperZincAll
Abstract: European Journal of Pediatrics ORIGINAL ARTICLE Serum zinc levels in pediatric patients with COVID‑19 Yıldız Ekemen Keleş1 · Dilek Yılmaz Çiftdoğan2 · Ayfer Çolak3 · Ahu Kara Aksay1 · Gülnihan Üstündag1 · Aslıhan Şahin1 · Nisel Yılmaz4 Received: 26 May 2021 / Revised: 18 November 2021 / Accepted: 13 December 2021 © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 Abstract Zinc has potent immunoregulatory and antiviral effects that are critical for growth, immunity, and neurologic development. The aim of this study was to determine the clinical significance of serum zinc levels in pediatric patients with COVID19 and to demonstrate its association with disease severity. This prospective observational study was conducted between August 3 and November 15, 2020, in pediatric patients aged 1 month to 18 years with confirmed COVID-19 using reverse transcription-polymerase chain reaction. We defined a control group whose serum zinc levels were determined 1 year ago at the same time as those of patients with COVID-19. We used 70 μg/dL as the cut-off zinc value to define zinc deficiency. Statistical analyses were performed using the SPSS for Windows statistics package program. One hundred children with confirmed COVID-19 and 269 children in the control group participated in the study. The median age was 13.3 (IQR: 8–15.4) years in patients with confirmed COVID-19, 11 patients had low serum zinc levels, and 89 patients had normal serum zinc levels. Patients in the group with low zinc levels had a significantly higher hospitalization rate than the group with normal zinc levels (5 (45.5%) and 10 patients (11.2%), respectively) (p = 0.011). The median serum zinc level in patients with COVID-19 was 88.5 mcg/dL (IQR 77.2–100), which was significantly lower than the median level in the control group, which was 98 mcg/dL (IQR 84–111) (p = 0.001). There was no association between the severity of COVID19 and the serum zinc levels of the children. Conclusion: Serum zinc levels may be influenced by many factors such as fasting status, diurnal variation, exercise, and sex, and may give an impression of the zinc status of the population rather than reflecting the individual. The fact that the incidence of hospitalization was significantly higher in patients with both COVID-19 and low serum zinc levels suggests that these patients require a detailed assessment of their living environment. What is Known: • Serum zinc levels have been found to be low in adult patients diagnosed with COVID-19. • There was a correlation between the severity of COVID-19 and serum zinc levels in adults. What is New: • Children with low serum zinc levels were found to have a higher number of hospitalizations. • No association was found between the severity of COVID-19 disease and serum zinc levels in children. Keywords Children · COVID-19 · Zinc · SARS-CoV-2 Keymessage PediatricCOVID-19 populations with low serum zinc levels may have an increased incidenceof hospitalization, and physicians are advised to exercise caution in thisregard. Communicated by Nicole Ritz * Yıldız Ekemen Keleş Extended author information available on the last page of the article Abbreviations SARS-CoV-2 Severe acute respiratory syndrome coronavirus-2 COVID-19 Coronavirus Disease-19 RT-PCR Reverse transcription-polymerase chain reaction IZiNCG International Zinc Nutrition..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop